Shares of Ventas, Inc. (NYSE:VTR) have received an average rating of “Hold” from the twenty analysts that are presently covering the company, Marketbeat Ratings reports. Six analysts have rated the stock with a sell rating, ten have given a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $42.27.

VTR has been the topic of a number of recent research reports. Wells Fargo & Co lifted their price objective on shares of Ventas from $29.00 to $35.00 and gave the company an “underweight” rating in a report on Friday, June 19th. Mizuho lowered their price objective on shares of Ventas from $60.00 to $31.00 and set a “neutral” rating on the stock in a report on Tuesday, April 21st. Jefferies Financial Group downgraded shares of Ventas from a “buy” rating to an “underperform” rating in a report on Tuesday, March 10th. Argus lowered their price objective on shares of Ventas from $67.00 to $35.00 and set a “buy” rating on the stock in a report on Wednesday, May 13th. Finally, BMO Capital Markets lifted their price objective on shares of Ventas from $32.00 to $40.00 and gave the company a “market perform” rating in a report on Wednesday, April 1st.

Large investors have recently added to or reduced their stakes in the stock. Utah Retirement Systems grew its stake in shares of Ventas by 1.9% in the fourth quarter. Utah Retirement Systems now owns 99,584 shares of the real estate investment trust’s stock valued at $5,750,000 after buying an additional 1,900 shares in the last quarter. Baird Financial Group Inc. boosted its position in Ventas by 9.3% during the fourth quarter. Baird Financial Group Inc. now owns 388,595 shares of the real estate investment trust’s stock worth $22,438,000 after purchasing an additional 33,104 shares during the period. Thrivent Financial for Lutherans boosted its position in Ventas by 8.1% during the first quarter. Thrivent Financial for Lutherans now owns 140,221 shares of the real estate investment trust’s stock worth $3,758,000 after purchasing an additional 10,532 shares during the period. HighTower Advisors LLC boosted its position in Ventas by 62.7% during the first quarter. HighTower Advisors LLC now owns 95,172 shares of the real estate investment trust’s stock worth $2,545,000 after purchasing an additional 36,675 shares during the period. Finally, Cipher Capital LP bought a new position in Ventas during the fourth quarter worth $2,732,000. 88.22% of the stock is owned by institutional investors and hedge funds.

VTR stock traded up $0.44 during mid-day trading on Friday, hitting $37.14. 65,536 shares of the company were exchanged, compared to its average volume of 4,845,719. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.86 and a current ratio of 2.86. The firm has a market cap of $13.69 billion, a P/E ratio of 17.48, a P/E/G ratio of 3.80 and a beta of 1.07. The firm’s 50 day simple moving average is $35.63 and its 200 day simple moving average is $43.42. Ventas has a 1-year low of $13.35 and a 1-year high of $75.40.

Ventas (NYSE:VTR) last announced its earnings results on Friday, May 8th. The real estate investment trust reported $0.97 EPS for the quarter, topping the consensus estimate of $0.89 by $0.08. The firm had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $969.85 million. Ventas had a net margin of 19.80% and a return on equity of 7.26%. The business’s quarterly revenue was up 7.3% on a year-over-year basis. During the same period last year, the company posted $0.35 EPS. On average, equities research analysts predict that Ventas will post 3.13 EPS for the current fiscal year.

About Ventas

Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, university-based research and innovation centers, inpatient rehabilitation and long-term acute care facilities, and health systems.

See Also: Commodities

Analyst Recommendations for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.